Results 171 to 180 of about 528,791 (356)
Loss of proton‐sensing GPR4 reduces tumor progression in mouse models of colon cancer
G protein‐coupled receptor 4 (GPR4) is a pH‐sensing receptor activated by acidic pH. GPR4 expression is increased in patients with inflammatory bowel disease who are at high risk of developing colorectal cancer. In mouse models, loss of GPR4 attenuated tumor progression. This correlated with increased IL2 and natural killer cell activity.
Leonie Perren+16 more
wiley +1 more source
Medical Concept Normalization in a Low-Resource Setting [PDF]
In the field of biomedical natural language processing, medical concept normalization is a crucial task for accurately mapping mentions of concepts to a large knowledge base. However, this task becomes even more challenging in low-resource settings, where limited data and resources are available.
arxiv
Initiatives for reducing medication errors: The time is now [PDF]
Neil M. Davis
openalex +1 more source
CINs of the cytoplasm: dissecting dsRNA signaling in chromosomal instability
Micronuclei, formed during cell division in chromosomal instability settings, rupture and lead to the accumulation of immunogenic double‐stranded RNA in the cytoplasm, activating MAVS‐dependent interferon signaling and innate antitumor immunity.
Aglaia Skolariki+2 more
wiley +1 more source
Resource-Efficient Medical Report Generation using Large Language Models [PDF]
Medical report generation is the task of automatically writing radiology reports for chest X-ray images. Manually composing these reports is a time-consuming process that is also prone to human errors. Generating medical reports can therefore help reduce the burden on radiologists.
arxiv
Impact of Internally Developed Electronic Prescription on Prescribing Errors at Discharge from the Emergency Department [PDF]
Introduction: Medication errors are common, with studies reporting at least one error per patient encounter. At hospital discharge, medication errors vary from 15%-38%.
Bakhti, Rinad+4 more
core
Using information technology to reduce rates of medication errors in hospitals [PDF]
David W. Bates
openalex +1 more source
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton+17 more
wiley +1 more source
New perspectives on preventing medication errors and adverse drug events [PDF]
Vicki S. Crane
openalex +1 more source
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop+10 more
wiley +1 more source